Profile | GDS5420 / 219437_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 739.18 | 74 |
GSM1296119 | B_lesional_pre-dose | 760.95 | 75 |
GSM1296076 | C_lesional_pre-dose | 136.12 | 48 |
GSM1296092 | D_lesional_pre-dose | 177.63 | 52 |
GSM1296103 | E_lesional_pre-dose | 882.31 | 77 |
GSM1296078 | F_lesional_pre-dose | 173.5 | 52 |
GSM1296107 | G_lesional_pre-dose | 943.08 | 78 |
GSM1296109 | H_lesional_pre-dose | 1355.44 | 84 |
GSM1296080 | I_lesional_pre-dose | 492.19 | 68 |
GSM1296090 | J_lesional_pre-dose | 219.1 | 55 |
GSM1296074 | K_lesional_pre-dose | 220.7 | 56 |
GSM1296111 | L_lesional_pre-dose | 684.81 | 73 |
GSM1296099 | M_lesional_pre-dose | 596.86 | 70 |
GSM1296086 | O_lesional_pre-dose | 221.45 | 55 |
GSM1296117 | P_lesional_pre-dose | 807.15 | 76 |
GSM1296113 | Q_lesional_pre-dose | 885.21 | 78 |
GSM1296096 | R_lesional_pre-dose | 522.97 | 68 |
GSM1296105 | S_lesional_pre-dose | 579.2 | 70 |
GSM1296098 | T_lesional_pre-dose | 964.09 | 79 |
GSM1296101 | U_lesional_pre-dose | 570.43 | 70 |
GSM1296121 | V_lesional_pre-dose | 826.52 | 76 |
GSM1296088 | W_lesional_pre-dose | 330.22 | 61 |
GSM1296082 | X_lesional_pre-dose | 240.41 | 57 |
GSM1296115 | Y_lesional_pre-dose | 725.09 | 74 |
GSM1296084 | Z_lesional_pre-dose | 375.48 | 63 |
GSM1296072 | B_lesional_day8 | 920.22 | 78 |
GSM1296069 | L_lesional_day8 | 709.54 | 74 |
GSM1296071 | P_lesional_day8 | 985.06 | 79 |
GSM1296070 | Y_lesional_day8 | 713.15 | 74 |
GSM1296073 | V_lesional_day8 | 551.99 | 70 |
GSM1296034 | A_lesional_day15 | 1337.73 | 84 |
GSM1296041 | G_lesional_day15 | 768.38 | 75 |
GSM1296035 | R_lesional_day15 | 547.12 | 69 |
GSM1296038 | U_lesional_day15 | 375.57 | 63 |
GSM1296047 | B_lesional_day15 | 830.38 | 76 |
GSM1296039 | E_lesional_day15 | 320.58 | 61 |
GSM1296042 | H_lesional_day15 | 643.3 | 72 |
GSM1296043 | L_lesional_day15 | 919.27 | 78 |
GSM1296037 | M_lesional_day15 | 464.6 | 66 |
GSM1296046 | P_lesional_day15 | 903.97 | 78 |
GSM1296044 | Q_lesional_day15 | 920.36 | 78 |
GSM1296045 | Y_lesional_day15 | 571.8 | 70 |
GSM1296025 | C_lesional_day15 | 666.76 | 72 |
GSM1296033 | D_lesional_day15 | 299.33 | 59 |
GSM1296027 | I_lesional_day15 | 179.21 | 52 |
GSM1296032 | J_lesional_day15 | 453.63 | 66 |
GSM1296024 | K_lesional_day15 | 902.74 | 77 |
GSM1296031 | W_lesional_day15 | 376.71 | 62 |
GSM1296028 | X_lesional_day15 | 304.46 | 59 |
GSM1296029 | Z_lesional_day15 | 297.71 | 59 |
GSM1296026 | F_lesional_day15 | 296.85 | 60 |
GSM1296030 | O_lesional_day15 | 242.97 | 57 |
GSM1296040 | S_lesional_day15 | 1022.02 | 79 |
GSM1296036 | T_lesional_day15 | 984.34 | 79 |
GSM1296048 | V_lesional_day15 | 678.43 | 73 |
GSM1296059 | A_lesional_day43 | 565.4 | 70 |
GSM1296066 | G_lesional_day43 | 921.93 | 78 |
GSM1296060 | R_lesional_day43 | 438.36 | 65 |
GSM1296063 | U_lesional_day43 | 209.77 | 53 |
GSM1296064 | E_lesional_day43 | 397.01 | 64 |
GSM1296067 | H_lesional_day43 | 956.53 | 79 |
GSM1296062 | M_lesional_day43 | 647.52 | 71 |
GSM1296068 | Q_lesional_day43 | 808.54 | 76 |
GSM1296050 | C_lesional_day43 | 205.17 | 53 |
GSM1296057 | D_lesional_day43 | 460.24 | 66 |
GSM1296052 | I_lesional_day43 | 231.82 | 56 |
GSM1296054 | J_lesional_day43 | 497.77 | 67 |
GSM1296049 | K_lesional_day43 | 422.77 | 65 |
GSM1296055 | W_lesional_day43 | 430.97 | 65 |
GSM1296053 | X_lesional_day43 | 508.34 | 67 |
GSM1296058 | Z_lesional_day43 | 445.33 | 66 |
GSM1296051 | F_lesional_day43 | 229.91 | 56 |
GSM1296056 | O_lesional_day43 | 345.59 | 62 |
GSM1296065 | S_lesional_day43 | 374.25 | 63 |
GSM1296061 | T_lesional_day43 | 1001.72 | 79 |
GSM1296095 | A_non-lesional_pre-dose | 626.58 | 72 |
GSM1296120 | B_non-lesional_pre-dose | 764.24 | 75 |
GSM1296077 | C_non-lesional_pre-dose | 438.48 | 66 |
GSM1296093 | D_non-lesional_pre-dose | 575.44 | 69 |
GSM1296104 | E_non-lesional_pre-dose | 429.49 | 65 |
GSM1296079 | F_non-lesional_pre-dose | 349.18 | 62 |
GSM1296108 | G_non-lesional_pre-dose | 1006.96 | 79 |
GSM1296110 | H_non-lesional_pre-dose | 1198.6 | 83 |
GSM1296081 | I_non-lesional_pre-dose | 669.1 | 72 |
GSM1296091 | J_non-lesional_pre-dose | 257.96 | 57 |
GSM1296075 | K_non-lesional_pre-dose | 262.36 | 58 |
GSM1296112 | L_non-lesional_pre-dose | 902.67 | 78 |
GSM1296100 | M_non-lesional_pre-dose | 775.2 | 75 |
GSM1296087 | O_non-lesional_pre-dose | 181.61 | 53 |
GSM1296118 | P_non-lesional_pre-dose | 1047.56 | 80 |
GSM1296114 | Q_non-lesional_pre-dose | 936.02 | 78 |
GSM1296097 | R_non-lesional_pre-dose | 542.16 | 69 |
GSM1296106 | S_non-lesional_pre-dose | 600.59 | 70 |
GSM1296102 | U_non-lesional_pre-dose | 660.13 | 72 |
GSM1296122 | V_non-lesional_pre-dose | 917.66 | 78 |
GSM1296089 | W_non-lesional_pre-dose | 364.19 | 62 |
GSM1296083 | X_non-lesional_pre-dose | 832.64 | 76 |
GSM1296116 | Y_non-lesional_pre-dose | 944.26 | 79 |
GSM1296085 | Z_non-lesional_pre-dose | 293.6 | 59 |